9,10-dimethyl-1,2-benzanthracene has been researched along with withaferin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manoharan, S; Nirmal, MR; Panjamurthy, K; Vellaichamy, L | 1 |
| Alias, LM; Balakrishnan, S; Manoharan, S; Menon, VP; Panjamurthy, K | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and withaferin a
| Article | Year |
|---|---|
Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cricetinae; Disease Models, Animal; Ergosterol; Humans; Male; Mesocricetus; Molecular Structure; Mouth Neoplasms; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Withanolides | 2009 |
Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Cricetinae; Drug Screening Assays, Antitumor; Ergosterol; Erythrocytes; Liver; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Mouth Neoplasms; Phytotherapy; Protective Agents; Thiobarbituric Acid Reactive Substances; Withanolides | 2009 |